# Whisk Products Inc – FDA 483, Jun 26, 2026

Source: https://www.keypedia.com/records/483/whisk-products-inc/322fa5f2-0a4b-425b-af08-c1decab0cd6f

> FDA 483 for Whisk Products Inc on June 26, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Whisk Products Inc
- Inspection Date: 2026-06-26
- Product Type: drugs
- Office Name: Kansas City District Office
- Summary: Whisk Products Inc, an OTC drug manufacturer in Wentzville, MO, received a Form FDA 483 with five observations highlighting significant deficiencies in their quality system. Issues included inadequate raw material testing, deficient quality control procedures, failure to investigate out-of-specification results, improper equipment cleaning, and an insufficient stability program, indicating a broad lack of adherence to current good manufacturing practices.

## Related Documents

- [483 - 2021-10-22](https://www.keypedia.com/records/483/whisk-products-inc/f6b782d2-14ff-4958-865b-d9317ba59df1) — date: October 22, 2021

## Related Officers

- [Scott D. Mcgrew](https://www.keypedia.com/people/scott-d-mcgrew/a9f36e0f-0ae6-42d1-98d2-14e324e2a7fc)

Company: https://www.keypedia.com/companies/whisk-products-inc/42cf456d-2936-4ec5-a2dd-b2e800bf2c11

Office: https://www.keypedia.com/offices/kansas-city-district-office/cd397ab1-df4e-46f1-ab1c-0f6db9abcf79